BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 31539779)

  • 1. Review about the multi-target profile of resveratrol and its implication in the SGK1 inhibition.
    Catalogna G; Moraca F; D'Antona L; Dattilo V; Perrotti G; Lupia A; Costa G; Ortuso F; Iuliano R; Trapasso F; Amato R; Alcaro S; Perrotti N
    Eur J Med Chem; 2019 Dec; 183():111675. PubMed ID: 31539779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic inhibition of SGK1 suppresses colorectal cancer.
    Liang X; Lan C; Jiao G; Fu W; Long X; An Y; Wang K; Zhou J; Chen T; Li Y; Xu J; Huang Q; Xu B; Xiao J
    Exp Mol Med; 2017 Nov; 49(11):e399. PubMed ID: 29170478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The SGK1 inhibitor SI113 induces autophagy, apoptosis, and endoplasmic reticulum stress in endometrial cancer cells.
    Conza D; Mirra P; Calì G; Tortora T; Insabato L; Fiory F; Schenone S; Amato R; Beguinot F; Perrotti N; Ulianich L
    J Cell Physiol; 2017 Dec; 232(12):3735-3743. PubMed ID: 28177128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SGK1, autophagy and cancer: an overview.
    Ghani MJ
    Mol Biol Rep; 2022 Jan; 49(1):675-685. PubMed ID: 34669124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-diabetic activity of fused PPARγ-SIRT1 ligands with limited body-weight gain by mimicking calorie restriction and decreasing SGK1 expression.
    Pirat C; Dacquet C; Leclerc V; Hennuyer N; Beucher-Gaudin M; Zanirato G; Géant A; Staels B; Ktorza A; Farce A; Caignard DH; Berthelot P; Lebegue N
    Eur J Med Chem; 2017 Sep; 137():310-326. PubMed ID: 28609708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preclinical model in HCC: the SGK1 kinase inhibitor SI113 blocks tumor progression in vitro and in vivo and synergizes with radiotherapy.
    Talarico C; D'Antona L; Scumaci D; Barone A; Gigliotti F; Fiumara CV; Dattilo V; Gallo E; Visca P; Ortuso F; Abbruzzese C; Botta L; Schenone S; Cuda G; Alcaro S; Bianco C; Lavia P; Paggi MG; Perrotti N; Amato R
    Oncotarget; 2015 Nov; 6(35):37511-25. PubMed ID: 26462020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum and Glucocorticoid Inducible Kinase 1-Sensitive Survival, Proliferation and Migration of Rhabdomyosarcoma Cells.
    Schmid E; Stagno MJ; Yan J; Schleicher S; Yu W; Honisch S; Lang F; Fuchs J; Seitz G
    Cell Physiol Biochem; 2017; 43(3):1301-1308. PubMed ID: 28992614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SI113, a SGK1 inhibitor, potentiates the effects of radiotherapy, modulates the response to oxidative stress and induces cytotoxic autophagy in human glioblastoma multiforme cells.
    Talarico C; Dattilo V; D'Antona L; Barone A; Amodio N; Belviso S; Musumeci F; Abbruzzese C; Bianco C; Trapasso F; Schenone S; Alcaro S; Ortuso F; Florio T; Paggi MG; Perrotti N; Amato R
    Oncotarget; 2016 Mar; 7(13):15868-84. PubMed ID: 26908461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanotechnology-based formulations for resveratrol delivery: Effects on resveratrol in vivo bioavailability and bioactivity.
    Santos AC; Pereira I; Pereira-Silva M; Ferreira L; Caldas M; Collado-González M; Magalhães M; Figueiras A; Ribeiro AJ; Veiga F
    Colloids Surf B Biointerfaces; 2019 Aug; 180():127-140. PubMed ID: 31035056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential Therapeutic Targets of Resveratrol, a Plant Polyphenol, and Its Role in the Therapy of Various Types of Cancer.
    Almatroodi SA; A Alsahli M; S M Aljohani A; Alhumaydhi FA; Babiker AY; Khan AA; Rahmani AH
    Molecules; 2022 Apr; 27(9):. PubMed ID: 35566016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The SGK1 Kinase Inhibitor SI113 Sensitizes Theranostic Effects of the 64CuCl2 in Human Glioblastoma Multiforme Cells.
    Catalogna G; Talarico C; Dattilo V; Gangemi V; Calabria F; D'Antona L; Schenone S; Musumeci F; Bianco C; Perrotti N; Amato R; Cascini GL
    Cell Physiol Biochem; 2017; 43(1):108-119. PubMed ID: 28848088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SGK1, the New Player in the Game of Resistance: Chemo-Radio Molecular Target and Strategy for Inhibition.
    Talarico C; Dattilo V; D'Antona L; Menniti M; Bianco C; Ortuso F; Alcaro S; Schenone S; Perrotti N; Amato R
    Cell Physiol Biochem; 2016; 39(5):1863-1876. PubMed ID: 27771704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resveratrol-maltol hybrids as multi-target-directed agents for Alzheimer's disease.
    Cheng G; Xu P; Zhang M; Chen J; Sheng R; Ma Y
    Bioorg Med Chem; 2018 Dec; 26(22):5759-5765. PubMed ID: 30360953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic Versatility of Resveratrol Derivatives.
    Nawaz W; Zhou Z; Deng S; Ma X; Ma X; Li C; Shu X
    Nutrients; 2017 Oct; 9(11):. PubMed ID: 29109374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a novel serum and glucocorticoid regulated kinase-1 (SGK1) ligand from virtual screening.
    Geldenhuys WJ; Talasila PK; Sadana P
    Bioorg Med Chem Lett; 2012 Sep; 22(17):5675-8. PubMed ID: 22858098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SI113, a specific inhibitor of the Sgk1 kinase activity that counteracts cancer cell proliferation.
    D'Antona L; Amato R; Talarico C; Ortuso F; Menniti M; Dattilo V; Iuliano R; Gigliotti F; Artese A; Costa G; Schenone S; Musumeci F; Abbruzzese C; Botta L; Trapasso F; Alcaro S; Paggi MG; Perrotti N
    Cell Physiol Biochem; 2015; 35(5):2006-18. PubMed ID: 25871776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic potential of serum and glucocorticoid inducible kinase inhibition.
    Lang F; Voelkl J
    Expert Opin Investig Drugs; 2013 Jun; 22(6):701-14. PubMed ID: 23506284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PI3K/SGK1/GSK3β signaling pathway is involved in inhibition of autophagy in neonatal rat cardiomyocytes exposed to hypoxia/reoxygenation by hydrogen sulfide.
    Jiang H; Xiao J; Kang B; Zhu X; Xin N; Wang Z
    Exp Cell Res; 2016 Jul; 345(2):134-40. PubMed ID: 26163895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SGK1 inhibition-induced autophagy impairs prostate cancer metastasis by reversing EMT.
    Liu W; Wang X; Wang Y; Dai Y; Xie Y; Ping Y; Yin B; Yu P; Liu Z; Duan X; Liao Z; Chen Y; Liu C; Li X; Tao Z
    J Exp Clin Cancer Res; 2018 Apr; 37(1):73. PubMed ID: 29609629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Derivatives and Analogues of Resveratrol: Recent Advances in Structural Modification.
    Li QS; Li Y; Deora GS; Ruan BF
    Mini Rev Med Chem; 2019; 19(10):809-825. PubMed ID: 30686253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.